Three-dimensional-software developer Voxar's CT colonography software, Colonscreen, will be used to interpret all virtual colonoscopy studies performed by the Special Interest Group in Gastrointestinal and Abdominal Radiology (SIGGAR1) clinical trial in the U.K., according to the Framingham, MA-based firm.
The SIGGAR1 trial, sponsored by the National Health Service (NHS) Health Technology Assessment (HTA) program, will compare CT colonography (virtual colonoscopy) with the two established alternatives, barium enema and optical, or conventional colonoscopy, for the diagnosis of colon cancer in older symptomatic patients.
The trial will involve 10 NHS hospitals around the U.K. in total, following a pilot at several institutions: St Mark’s Hospital in Harrow; Bradford Royal Infirmary in Bradford; Hope Hospital in Salford; and the Queen Elizabeth Hospital in Birmingham. The remaining six centers, currently being recruited, will join the trial this September, Voxar said.
A total of 4,320 patients will be involved in the trial, which ends in April 2006. The trial will result in clinical guidelines for the use of CT colonography for cancer diagnosis in the U.K.
By AuntMinnie.com staff writersJuly 8, 2004
Related Reading
Voxar expands 3D software, May 25, 2004
Voxar releases Colonscreen 2.3, May 7, 2004
Voxar adds to client list, April 5, 2004
Voxar lands New York sale, March 17, 2004
Agfa adds Voxar 3D, March 5, 2004
Copyright © 2004 AuntMinnie.com
